Introduction
============

Toluene diisocyanate (TDI) is a low molecular weight compound used in the production of polyurethane foams, automobile paint, varnishes and related products. Long-term exposure to TDI can lead to the development of TDI-induced occupational asthma (OA), a common OA in industrialized countries worldwide.^[@bib1]^ TDI-OA has a poor prognosis and its pathogenesis is not completely understood, but could be more complicated than that of non-occupational asthma (NOA). Exposure to TDI directly damages airway epithelium, leading to increased airway epithelial permeability. Moreover, TDI exposure activates airway epithelial cells, which produce cytokines and recruit inflammatory cells such as neutrophils into the airways, which then enhances the airway inflammation and leads to a severe asthma phenotype.^[@bib2],\ [@bib3]^

Folliculin (FLCN) is expressed in the skin, kidneys, and upper and lower airway epithelial cells.^[@bib4]^ Mutations in the *FLCN* gene have been implicated in Birt--Hogg--Dube syndrome, which is characterized by lung cysts and spontaneous pneumothorax.^[@bib5],\ [@bib6]^ Recent studies have reported the role of FLCN in maintaining the integrity and function of airway epithelial cells and lung fibroblasts. Knockout of FLCN induced apoptosis, downregulated the expression of E-cadherin in mouse lung alveolar cells and damaged several signaling pathways in human airway epithelial cells (HAECs).^[@bib7],\ [@bib8]^ These findings suggest that FLCN may involve in chronic airway diseases that involve airway damage. However, to date, the involvement of FLCN in OA and NOA is unknown.

In this study, we measured the serum levels of FLCN in patients with TDI-OA, asymptomatic TDI-exposed controls (AECs), NOA patients and unexposed normal healthy controls (NCs) to evaluate the involvement of FLCN in these diseases. We also investigated the effects of TDI and neutrophil inflammation on HAEC activation and their production of FLCN.

Materials and methods
=====================

Subject recruitment
-------------------

We recruited 212 TDI-exposed workers (including 93 TDI-OA patients and 119 AECs), 200 NOA patients and 71 NCs from Ajou University Medical Center (Suwon, South Korea). TDI-OA was diagnosed by a positive response to a TDI bronchoprovocation test, as previously described.^[@bib9]^ A diagnosis of Birt--Hogg--Dube syndrome was excluded based on disease history and chest X-ray. One week before serum collection, the TDI-OA and NOA patients stopped using leukotriene modifiers and anti-inflammatory agents, including inhaled or oral corticosteroid. Serum samples were collected at the time of diagnosis and stored at −70 °C until use. Atopy status was defined as one or more positive reactions on skin prick tests with 55 common aeroallergens (Bencard, Bradford, UK).^[@bib9]^ All of the study subjects provided written informed consent. The study was approved by the Institutional Review Board of Ajou University Medical Center.

Detection of serum-specific IgG and sIgE antibodies to TDI-human serum albumin conjugate by enzyme-linked immunosorbent assay
-----------------------------------------------------------------------------------------------------------------------------

Vapor-type TDI-human serum albumin (TDI-HSA) and mock-HSA conjugates were kindly provided by Dr Adam Wisnewski (Yale University, New Haven, CT, USA). Serum-specific IgG (sIgG) and serum-specific (sIgE) antibodies to TDI-HSA were detected using a homemade enzyme-linked immunosorbent assay (ELISA), as previously described.^[@bib9],\ [@bib10]^

ELISA to measure serum levels of FLCN and interleukin-8
-------------------------------------------------------

Commercial ELISA kits were used to measure the serum levels of FLCN (CUSABIO Biotech, Wuhan, Hubei Province, China) and interleukin-8 (IL-8) (Endogen, Woburn, MA, USA), as well as the levels in cell culture supernatants, following the manufacturer's protocols.

Isolation of peripheral blood neutrophils
-----------------------------------------

Blood samples were collected from healthy donors into BD Vacutainer tubes containing acid citrate dextrose solution (BD Biosciences, Franklin Lakes, NJ, USA), stored at room temperature (RT), and were processed within 2 h of collection. Peripheral blood neutrophils (PBNs) were isolated by gradient centrifugation on Lymphoprep solution (Axis-Shield, Oslo, Norway), followed by sedimentation in Hank's balanced salt solution buffer containing 2% dextran (Polysciences, Warrington, PA, USA), as previously described.^[@bib11]^ Cell viability (\>98%) was assessed by trypan blue staining. Cell purity (\>95%) was assessed by hematoxylin and eosin (H&E) staining and flow cytometry using CD68 and CD11b expression.

HAEC culture and treatment
--------------------------

A human lung carcinoma cell line (A549) was purchased from the American Type Culture Collection (Manassas, VA, USA) and cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 U ml^−1^ penicillin G sodium and 100 μg ml^−1^ streptomycin sulfate (all from Gibco, Grand Island, NY, USA). Cells were maintained at 37 °C with 5% CO~2~ in humidified air. Cells (2 × 10^5^) were seeded onto each well of a 12-well plate (TPP, Trasadingen, Switzerland) and treated with 2--200 μg ml TDI-HSA in serum-free RMPI-1640 medium. Mock-HSA conjugate was used as a control (data not shown). In co-culture experiments, different numbers of PBNs were added onto A549 cells in serum-free medium. After a 24 h incubation, the supernatant was collected, and the cells were lysed in a radioimmunoprecipitation assay buffer and stored at −70 °C for further experiments.

Western blotting to detect FLCN
-------------------------------

The proteins (30 μg) from A549 cell lysates were loaded onto 10% SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA). After blocking in 5% skim milk (Sigma, St Louis, MO, USA) in PBS containing 0.05% Tween 20 (PBS-T) for 1 h at RT, the membranes were incubated with rabbit anti-human FLCN antibody (Cell Signaling, Minneapolis, MN, USA) overnight at 4 °C. Then the membranes were washed three times with PBS-T for 10 min each, and incubated with the appropriate secondary antibody for 1 h at RT. The membranes were blotted with anti-beta actin as a loading control. Signals were detected using ECL Plus Western Blotting Detection Reagents (GE Healthcare, Little Chalfont, UK). The intensity of bands was analyzed using a gel doc system (Bio-Rad).

Statistical analysis
--------------------

The serum levels of FLCN in the study subjects were log-transformed before statistical analysis to establish a normal distribution. Data for continuous variables were compared using the Student's *t-*test or Mann--Whitney *U-*test; Pearson's *χ*^2^ or Fisher's exact tests were used for categorical variables. Statistical correlations were analyzed using Pearson's coefficient or Spearman's rank coefficient. All of the statistical analyses were performed with SPSS ver. 22.0 (SPSS, Chicago, IL, USA). *P* values \<0.05 were considered statistically significant. GraphPad Prism 5.0 (GraphPad, San Diego, CA, USA) was used for graphs, with values presented as the mean±standard deviation (s.d.) of at least three independent experiments.

Results
=======

Clinical characteristic of the study subjects
---------------------------------------------

Females predominated in the NOA (60.0%) and NC (60.6%) groups, whereas males predominated in the TDI-OA (69.9%) and AEC (68.1%) groups ([Table 1](#tbl1){ref-type="table"}). The duration of TDI exposure of TDI-OA patients (6.19±4.3 years) was significantly shorter than that of AEC group (12.05±8.2 years, *P*=0.003). The prevalence of sIgG and sIgE antibodies against TDI-HSA in the TDI-OA group was significantly higher than that in the AEC group (23.8% vs 5.9% and 23.5% vs 1.7%, respectively; both *P*\<0.001). No differences in serum levels of total IgE or asthma duration were observed between the TDI-OA and NOA groups.

Elevated serum levels of FLCN in TDI-exposed subjects and NOA patients
----------------------------------------------------------------------

We log-transformed the serum level of FLCN to correct its skewed distribution. Serum levels of FLCN ([Figure 1a](#fig1){ref-type="fig"}) of the TDI-OA (1.57±0.31), AEC (1.64±0.31) and NOA (1.50±0.24) groups were all significantly higher than those of the NC group (1.31±0.21, all *P*\<0.001). The serum levels of FLCN in both the TDI-OA and AEC groups were significantly higher than those in the NOA group (*P*=0.038 and *P*\<0.001, respectively). We classified the study subjects into two groups with high (FLCN-high) and low (FLCN-low) serum levels of FLCN using a cutoff value (1.75) calculated as the mean plus two s.d.'s of the serum level of FLCN of the NC group. The prevalence of FLCN-high subjects in the TDI-OA (33.3%) and AEC (38.7%) groups did not significantly differ (*P*=0.473), whereas both were significantly higher than the NOA group (16.5%, *P*=0.002 vs TDI-OA and *P*\<0.001 vs AEC). The prevalence of FLCN-high subjects in the NC group (4.2%) was significantly lower than that in the other three groups (*P*\<0.001 for all). Consequently, TDI-exposed subjects (including TDI-OA and AEC subjects) had significantly higher serum levels of FLCN (1.61±0.31) and significantly higher prevalence of FLCN-high subjects (36.3%) than the NOA and NC groups (all *P*\<0.001, [Figure 1b](#fig1){ref-type="fig"}).

Associations of serum levels of FLCN with clinical parameters
-------------------------------------------------------------

We observed that the serum levels of FLCN were positively correlated with TDI-exposure duration (*r*=0.251, *P*=0.027, [Figure 2a](#fig2){ref-type="fig"}), but were negatively correlated with asthma duration of the TDI-OA patients (*r*=−0.329, *P*=0.029, [Figure 2b](#fig2){ref-type="fig"}). Nevertheless, no significant correlation between serum levels of FLCN and asthma duration of NOA group was noted (*r*=−0.182, *P*=0.295). The TDI-exposed FLCN-high subjects were also significantly older (*P*=0.029) and had higher serum levels of total IgE (*P*=0.021) than the FLCN-low subgroup ([Table 2](#tbl2){ref-type="table"}). No associations of serum levels of FLCN with the prevalence of serum sIgE or sIgG to TDI-HSA or serum levels of IL-8 were observed.

Effect of TDI exposure on FLCN production from HAECs
----------------------------------------------------

When A549 cells were treated with 2--200 μg ml^−1^ TDI-HSA conjugate, TDI-HSA dose-dependently increased both the intracellular expression ([Figure 3a](#fig3){ref-type="fig"}) and extracellular release ([Figure 3b](#fig3){ref-type="fig"}) of FLCN compared to mock-HSA treatment. TDI-HSA also induced IL-8 production from A549 cells in a dose-dependent manner ([Figure 3c](#fig3){ref-type="fig"}), which was strongly correlated with the FLCN level released from those cells (*r*=0.779, *P*=0.003, [Figure 3d](#fig3){ref-type="fig"}). TDI-HSA did not affect A549 cell viability at the tested concentrations ([Figure 3e](#fig3){ref-type="fig"}).

Neutrophils induce FLCN production from A549 cells
--------------------------------------------------

Neutrophilic airway inflammation contributes to TDI-OA development.^[@bib2]^ Because TDI-HSA induced A549 cells to produce IL-8, a strong neutrophil chemoattractant, we evaluated the role of neutrophils in FLCN production by HAECs. A549 cells were co-cultured with PBNs at different cell number ratios. We observed that PBNs significantly increased both the intracellular expression ([Figure 4a](#fig4){ref-type="fig"}) and extracellular release ([Figure 4b](#fig4){ref-type="fig"}) of FLCN from A549 cells in a dose-dependent manner.

Discussion
==========

Toluene diisocyanate exposure directly damaged HAECs and activated their inflammatory response, leading to airway epithelium impairment and the infiltration of inflammatory cells into the airways.^[@bib2]^ FLCN is a protein expressed by airway epithelial cells that regulates the survival and adherence of alveolar epithelial cells.^[@bib7]^ Recently, FLCN has been detected in the bronchial alveolar lavage fluid from asthmatic patients, suggesting a role in asthma.^[@bib12]^ Nevertheless, the function of FLCN in asthma and its involvement in TDI-OA have not been studied. This is the first study to describe increased serum levels of FLCN in TDI-exposed workers, including TDI-OA and AEC groups, as well as NOA patients compared to normal healthy subjects. We also found that TDI exposure induced the concomitant release of FLCN and IL-8 from A549 cells, which was also induced by co-culture of A549 cells with PBNs. These findings suggest the involvement of FLCN in airway inflammation in TDI-exposed subjects.

A previous study found increased FLCN secretion from compressed human bronchial epithelial cells,^[@bib12]^ suggesting that FLCN is released from HAECs in asthmatic patients. Consistently, we found higher serum FLCN levels in both TDI-OA and NOA patients compared to healthy subjects, implicating FLCN in the pathogenesis of asthma. We also observed higher production of serum FLCN in TDI-OA and AEC subjects compared to the NOA and NC groups, as well as a positive correlation of serum FLCN levels with TDI-exposure duration, but not with the asthma duration of NOA patients. These findings suggest that TDI is a stronger inducer of FLCN production. The role of FLCN in TDI-OA and asthma has not been investigated, although several studies have suggested that FLCN has a protective function maintaining the integrity and survival of HAECs.^[@bib7],\ [@bib13]^ Moreover, serum levels of FLCN were negatively correlated with disease duration of the TDI-OA patients, which suggests that long-term airway epithelial cell damage induced by TDI could lead to the reduced production of FLCN. Overall, we speculate that increased expression or secretion of FLCN upon TDI exposure is not only a consequent response but also a protective mechanism against TDI-induced airway damage. The function of FLCN in TDI-OA and NOA remains to be investigated.

The consequences of the aging process have been implicated in innate immune responses, including HAEC dysfunction and increased neutrophils infiltrating into airways of asthmatics.^[@bib14]^ We observed that TDI-exposed subjects who had high serum levels of FLCN were older than FLCN-low subjects, suggesting that the aging process affects FLCN production from HAECs. Moreover, airway epithelium is a barrier to the infiltration of allergens into the subepithelial layers where they interact with antigen-presenting cells, which could regulate allergen-specific antibody production.^[@bib15]^ Therefore, the association of serum levels of FLCN and total serum levels of IgE observed in this study may be an epiphenomenon that resulted from airway damage and increased airway permeability induced by TDI exposure.

To validate our hypothesis that TDI exposure induces FLCN production from HAECs, we treated A549 cells with TDI-HSA conjugate, which dose-dependently increased both the intracellular expression and extracellular release of FLCN. Moreover, the TDI-HSA conjugate stimulated A549 cells to produce IL-8, which could be considered an activation maker of HAECs.^[@bib9],\ [@bib16]^ Interestingly, the extracellular FLCN levels strongly correlated with the IL-8 levels. These findings suggest that TDI exposure activates HAECs to produce FLCN, explaining the elevated serum FLCN levels in TDI-exposed subjects. However, the increased FLCN level in NOA patients could be a consequence of bronchial contraction,^[@bib12]^ whereas that in TDI-exposed subjects is induced by direct stimulatory effects of TDI. The mechanisms underlying the TDI-induced FLCN expression need further investigation.

Previously, we reported higher numbers of neutrophils infiltrating the airways of TDI-OA patients compared to AEC and NOA subjects,^[@bib17]^ suggesting the contribution of neutrophils to the development of airway inflammation in TDI-OA. Moreover, we consistently found that TDI exposure stimulates HAECs to produce IL-8, a well-known neutrophil chemoattractant.^[@bib2],\ [@bib18]^ Consequently, we elucidated the role of neutrophils in FLCN production from HAECs in this study. Co-culture with PBNs significantly increased FLCN expression and release from A549 cells, suggesting that TDI-induced neutrophil infiltration of the airway enhances the production of FLCN by HAECs. However, we did not find any correlation between serum levels of FLCN and sputum neutrophil count or serum levels of IL-8 in TDI-exposed subjects. Perhaps FLCN production in TDI-exposed subjects is also affected by various factors that participate in the airway inflammation process.

In addition, we observed the increased serum FLCN level from TDI-exposed subjects regardless the development of TDI-OA. It is known that the development of TDI-OA depends on various mechanisms, including immunologic, non-immunologic and genetic molecular mechanisms.^[@bib19]^ We speculate that FLCN is not a determining factor, but involved in TDI-OA by interacting with other factors, which needs to be investigated further.

In conclusion, TDI exposure and TDI-induced neutrophil recruitment into the airways directly activates HAECs and stimulates them to produce FLCN, could be involved in airway inflammation in workers exposed to TDI.
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![Comparison of serum FLCN levels among the four study groups (**a**) and among the TDI-exposed subjects (including TDI-OA and AEC groups), NOA and NC groups (**b**). Dot plots show the log-transformed serum FLCN level. Horizontal dashed lines indicate the cutoff value, and horizontal solid lines in the middle of the dot plots indicate the mean value of each group. The *P*-value was obtained using Fisher's exact test to compare the prevalence of subjects with high serum FLCN levels (%) among the indicated groups. AEC, asymptomatic TDI-exposed controls; FLCN, folliculin; NC, normal healthy controls; NOA, non-occupational adult asthma; TDI-OA, TDI-induced occupational asthma.](emm2017180f1){#fig1}

![Correlation of serum FLCN level with TDI exposure duration in TDI-exposed subjects (**a**) and disease duration of TDI-OA patients (**b**). Spearman's rank coefficient was applied for the test. FLCN, folliculin; TDI, toluene diisocyanate; TDI-OA, TDI-induced occupational asthma.](emm2017180f2){#fig2}

![TDI-HSA conjugate-induced FLCN and IL-8 production from A549 cells. A549 cells were treated with TDI-HSA or mock-HSA (negative control) for 24 h. (**a**) The intracellular expression of FLCN was evaluated by western blotting. The levels of FLCN (**b**) and IL-8 (**c**) released to the culture supernatants were evaluated by ELISA. (**d**) Correlation of FLCN and IL-8 levels in the culture supernatants. (**e**) Effect of TDI-HSA conjugate on A549 cell viability was assessed using a Cell Counting Kit 8. \**P*\<0.05, \*\**P*\<0.01 obtained by one-way ANOVA with Bonferroni's *post hoc* test. FLCN, folliculin; HAS, human serum albumin; IL, interleukin; NS, not significant.](emm2017180f3){#fig3}

![Peripheral blood neutrophils-induced FLCN expression and release from A549 cells. A549 cells (2 × 10^5^ cells) were co-cultured with peripheral blood neutrophils for 24 h. (**a**) Intracellular FLCN expression was evaluated by western blotting. (**b**) The levels of FLCN released to the culture supernatants were measured by ELISA. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001 vs control, obtained by one-way ANOVA with Bonferroni's *post hoc* test. FLCN, folliculin.](emm2017180f4){#fig4}

###### Clinical characteristic of the study subjects

                                                                                                                         P*-value*                                 
  ---------------------------------------------------------- --------------- -------------- --------------- ------------ ------------- ------------- ------------- -------------
  Age[a](#t1-fn2){ref-type="fn"}                             42.8±10.5       40.57±8.7      44.66±15.8      39.75±14.0   0.122         0.280         0.073         0.366
  Sex (female)[b](#t1-fn3){ref-type="fn"}                    28 (30.1)       38 (31.9)      120 (60.0)      43 (60.6)    0.776         **\<0.001**   **\<0.001**   **\<0.001**
  Atopy[b](#t1-fn3){ref-type="fn"}                           38/77 (49.35)   NA             89/186 (47.8)   NA           NA            0.945         NA            NA
  FEV~1~ (% predicted)[a](#t1-fn2){ref-type="fn"}            84.7±21.78      90.17±20.24    89.29±20.78     NA           0.476         0.100         NA            NA
  MchPC~20~ (mg ml^−1^)[a](#t1-fn2){ref-type="fn"}           7.04±13.39      7.94±9.35      12.42±12.04     NA           0.266         **\<0.001**   NA            NA
  Serum total IgE (IU l^−1^)[a](#t1-fn2){ref-type="fn"}      327.2±497.9     231.05±618.9   409.75±719.16   NA           0.097         0.294         NA            NA
  TDI exposure duration (years)[a](#t1-fn2){ref-type="fn"}   6.19±4.3        12.05±8.2      NA              NA           **0.003**     NA            NA            NA
  Asthma duration (years)[a](#t1-fn2){ref-type="fn"}         6.68±4.11       NA             7.2±6.58        NA           NA            0.619         NA            NA
  sIgG to TDI-HSA[b](#t1-fn3){ref-type="fn"}                 19/80 (23.8)    7/119 (5.9)    NA              NA           **\<0.001**   NA            NA            NA
  sIgE to TDI-HSA[b](#t1-fn3){ref-type="fn"}                 19/81 (23.5)    2/119 (1.7)    NA              NA           **\<0.001**   NA            NA            NA

Abbreviations: AEC, asymptomatic TDI-exposed control; FEV1, forced expiratory volume in 1 s; MchPC20, concentration of methacholine required to produce a 20% decrease in FEV1; NA, not available; NC, normal healthy control; NOA, non-occupational adult asthma; sIgG and sIgE, serum-specific IgG and IgE antibody; TDI-HSA, toluene diisocyanate-human serum albumin conjugate; TDI-OA, TDI-induced occupational asthma.

Data are shown as the mean±s.d., *P*-value obtained with the Mann--Whitney *U*-test.

Data are shown as the prevalence (%), *P-*value obtained with the *χ*^2^ test.

Bold numbers indicate statistically significant values.

###### Comparison of the clinical and immunological features according to the level of serum FLCN in TDI-exposed subjects

                                                           *Serum FLCN level*                    
  -------------------------------------------------------- -------------------- ---------------- -----------
  Age (years)[a](#t2-fn2){ref-type="fn"}                   43.55±9.75/75        40.38±9.24/133   **0.029**
  Atopy[b](#t2-fn3){ref-type="fn"}                         16/24 (66.7)         24/54 (44.4)     0.088
  Sex (female)[b](#t2-fn3){ref-type="fn"}                  20/77 (26.0)         46/135 (34.1)    0.280
  Asthma duration (years)[a](#t2-fn2){ref-type="fn"}       5.92±4.03/12         6.97±4.16/32     0.524
  FEV1 (% predicted)[a](#t2-fn2){ref-type="fn"}            81.06±15.85/22       87.79±23.49/47   0.168
  MchPC20 (mg ml^−1^)[a](#t2-fn2){ref-type="fn"}           6.27±11.76/23        7.53±13.36/56    0.791
  Serum total IgE (IU ml^−1^)[a](#t2-fn2){ref-type="fn"}   410.5±723.9/40       241.3±401.2/78   **0.021**
  Serum sIgG to TDI-HSA[b](#t2-fn3){ref-type="fn"}         6/71 (8.5)           20/128 (15.6)    0.190
  Serum sIgE to TDI-HSA[b](#t2-fn3){ref-type="fn"}         8/72 (11.1)          13/128 (10.2)    0.815
  Serum IL-8 (pg ml^−1^)[a](#t2-fn2){ref-type="fn"}        48.06±72.89/69       58.9±139.1/127   0.777

Abbreviations: FEV1, forced expiratory volume in 1 s; IL-8, interleukin 8; MchPC20, concentration of methacholine required to produce a 20% decrease in FEV1; sIgG and sIgE, serum-specific IgG and IgE antibody; TDI-HSA, toluene diisocyanate-human serum albumin conjugate

Data are shown as the mean±s.d., *P*-value obtained with the Mann--Whitney *U*-test.

Data are shown as the prevalence (%), *P-*value obtained with the *χ*^2^ test.

Bold numbers indicate statistically significant values.
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